×
For best experience we recommend to activate Javascript in your browser.
Recombinant AOC3 (Timolumab Biosimilar) antibody
The Human Monoclonal anti-AOC3 (Timolumab Biosimilar) antibody (ABIN7675828) specifically detects AOC3 (Timolumab Biosimilar) in BLI, ELISA, FACS, Func and SPR.
The antibody is reactive with Human samples.
Catalog No. ABIN7675828
$346.15
Plus shipping costs $50.00
1 mg ABIN7581248
100 μg ABIN7675828
1 mg ABIN7581248
100 μg ABIN7675828
Delivery in 10 to 12 Business Days
Quick Overview for Recombinant AOC3 (Timolumab Biosimilar) antibody (ABIN7675828)
Target
AOC3 (Timolumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
All hosts for AOC3 (Timolumab Biosimilar) antibodies
Human
Clonality
All clonalities for AOC3 (Timolumab Biosimilar) antibodies
Monoclonal
Conjugate
All conjugates for AOC3 (Timolumab Biosimilar) antibodies
This AOC3 (Timolumab Biosimilar) antibody is un-conjugated
Application
Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)
Product Details anti-AOC3 (Timolumab Biosimilar) Antibody
(hide)
Expression System
CHO Cells
Purpose
Anti-AOC3 / VAP1 Reference Antibody (timolumab)
Characteristics
Anti-AOC3 / VAP1 Reference Antibody (timolumab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
Purity
>95 %
Isotype
IgG4 S228P
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Lyophilized
Concentration
1 mg/mL
Buffer
25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
Storage
4 °C,-80 °C
Storage Comment
+4°C,-80°C
Target Details for AOC3 (Timolumab Biosimilar)
(hide)
Target
AOC3 (Timolumab Biosimilar)
Target Type
Biosimilar
Molecular Weight
145.5 kDa
UniProt
Q16853
Recently viewed
(hide)
You are here:
Homepage
Recombinant anti-AOC3 (Timolumab Biosimilar) antibody (ABIN7675828)
Chat with us , powered by LiveChat